Skip to main content
. 2021 Jan 5;18(1):326. doi: 10.3390/ijerph18010326

Table 3.

Hazard ratios of risk of death among dialysis patients with RCT and without RCT.

Variables Univariate Multivariate
HR 95% CI p HR 95% CI p
Age 1.09 1.06–1.10 <0.001 * 1.07 1.05–1.09 <0.001 *
Men (Women §) 1.15 0.97–1.34 0.082 1.11 0.91–1.29 0.273
Monthly income
(No income §)
NT$1–15,840 0.80 0.61–1.04 0.062 0.99 0.86–1.31 0.704
NT$15,841–25,000 0.79 0.62–0.93 0.009 * 0.84 0.78–1.24 0.677
≥NT$25,001 0.56 0.40–0.71 <0.001 * 0.79 0.60–1.03 0.125
HD (PD §) 1.23 0.90–1.63 0.172 0.74 0.58–0.97 0.048 *
Diabetes mellitus (yes vs. no) 3.10 2.69–3.63 <0.001 * 1.92 1.53–2.35 <0.001 *
Hypertension (yes vs. no) 2.24 1.83–2.59 <0.001 * 1.12 0.89–1.49 0.569
Hyperlipidemia (yes vs. no) 1.93 1.58–2.35 <0.001 * 1.06 0.72–1.33 0.611
Gout (yes vs. no) 1.56 1.29–1.96 <0.001 * 0.94 0.60–1.35 0.377
Congestive heart failure (yes vs. no) 2.91 2.21–3.72 <0.001 * 1.30 0.99–1.66 0.051
Coronary artery disease (yes vs. no) 3.01 2.53–3.68 <0.001 * 1.59 1.28–1.92 <0.001 *
Cerebrovascular accident
(yes vs. no)
2.97 2.31–3.51 <0.001 * 1.42 1.19–1.79 <0.001 *
Peripheral arterial disease (yes vs. no) 1.43 0.65–2.99 0.358 0.90 0.40–1.99 0.835
Chronic lung disease (yes vs. no) 2.64 2.19–3.29 <0.001 * 1.42 1.14–1.75 0.001 *
Chronic liver disease (yes vs. no) 1.95 1.57–2.53 <0.001 * 1.59 1.29–2.03 <0.001 *
Malignancy (yes vs. no) 1.83 1.35–2.49 <0.001 * 1.48 1.18–2.18 0.004 *
Retinopathy (yes vs. no) 2.21 1.82–2.61 <0.001 * 1.20 0.92–1.45 0.077
RCT (vs. non-RCT §) 0.59 0.44–0.79 <0.001 * 0.69 0.51–0.90 0.001 *

* p < 0.05; § ref. HR = hazard ratio; CI = confidence interval; HD = Hemodialysis; PD = Peritoneal dialysis.